MedTrace Logo

The Role of Nerve Blocks in Hip Arthroscopy

NCT03506620 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2020-05-20

No results posted yet for this study

Summary

The goal of this study is to determine whether QL blocks reduce opioid consumption following arthroscopic hip surgery by decreasing postoperative pain. Considering the current opioid epidemic, the responsibility of physicians to help prevent addiction, and the increasing prevalence of arthroscopic hip surgeries, this study holds a tremendous potential benefit for future patients.

Conditions

  • Femoroacetabular Impingement

Interventions

DRUG

Ropivacaine injection

Naropin (Ropivacaine HCl) 0.25%; Dose: 20 cc

DRUG

Saline Solution for Injection

20 cc of saline will be injected in the form of a QL block as a placebo.

Sponsors & Collaborators

Principal Investigators

  • Thomas S Lynch, M.D. · Columbia University Department of Orthopedics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-31
Primary Completion
2020-02-07
Completion
2020-02-07
FDA Drug
Yes

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03506620 on ClinicalTrials.gov